analyst
AN
NASDAQ · ANNX
Annexon, Inc.
Healthcare · Biotechnology
$4.20
Down-$0.17 (-4.05%)
Updated Oct 6, 2026, 10:38 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 669.73M
- P/E ratio
- -4.03
- Dividend yield
- 0.00%
- 52-week range
- $3.63 – $6.62
- Volume
- 3.45M
- Avg. volume
- 2.57M
Price performance · ANNX
ANNX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
ANNX closed at $4.20 after 20 trading sessions, down 10.06% for the selected period.
- Last close
- $4.20
- Period change
- -10.06%
- Period low
- $3.64
- Period high
- $4.67
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $4.25 | $4.31 | $4.06 | $4.20 | 3.45M |
| Oct 2, 2026 | $4.21 | $4.265 | $4.105 | $4.19 | 4.02M |
| Oct 1, 2026 | $4.18 | $4.38 | $4.12 | $4.12 | 3.92M |
| Sep 30, 2026 | $4.19 | $4.27 | $4.05 | $4.23 | 4.41M |
| Sep 29, 2026 | $4.00 | $4.2372 | $3.94 | $4.13 | 3.71M |
| Sep 28, 2026 | $3.85 | $4.08 | $3.735 | $4.01 | 5.07M |
| Sep 25, 2026 | $3.81 | $3.85 | $3.63 | $3.64 | 3.51M |
| Sep 24, 2026 | $3.85 | $3.87 | $3.725 | $3.80 | 2.02M |
| Sep 23, 2026 | $4.18 | $4.19 | $3.81 | $3.87 | 2.42M |
| Sep 22, 2026 | $4.28 | $4.34 | $4.13 | $4.18 | 2M |
| Sep 21, 2026 | $4.27 | $4.358 | $4.12 | $4.22 | 4.19M |
| Sep 18, 2026 | $4.16 | $4.31 | $4.13 | $4.23 | 4.94M |
| Sep 17, 2026 | $3.922 | $4.22 | $3.915 | $4.17 | 3.12M |
| Sep 16, 2026 | $3.91 | $4.00 | $3.875 | $3.93 | 4.52M |
| Sep 15, 2026 | $3.93 | $3.975 | $3.79 | $3.92 | 2.96M |
| Sep 14, 2026 | $3.97 | $4.035 | $3.88 | $3.95 | 2.9M |
| Sep 11, 2026 | $4.195 | $4.195 | $3.92 | $3.94 | 3.94M |
| Sep 10, 2026 | $4.33 | $4.33 | $4.04 | $4.14 | 4.2M |
| Sep 9, 2026 | $4.60 | $4.66 | $4.34 | $4.37 | 5.53M |
| Sep 8, 2026 | $4.76 | $4.785 | $4.64 | $4.67 | 2.14M |
Latest ANNX news
The latest Smart Investors Daily articles mentioning ANNX.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…